Gain Therapeutics, Inc. (GANX) stock
GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.18+0.24 (+25.51%)
Close on Nov 17, 2026Market cap $51.50MP/E –Yield –
Gain Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Gain Therapeutics's price to sales ratio was 495.8× on Nov 30, 2023, against 194.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Nov 30, 2023 | 495.8× | +292.9 |
| 2022 | Dec 30, 2022 | 202.9× | −289.8 |
| 2021 | Dec 31, 2021 | 492.7× | – |
See a number that looks wrong?